A pharmacist has shared the possible pain-relieving benefits of the type 2 diabetes drug Mounjaro, which could help millions ...

Mounjaro may also be used for other conditions as determined by your GP. It's possible that Mounjaro might help ease some ...

Endometriosis is a gynaecological condition where tissue similar to the lining of the uterus grows outside the uterus. It can ...

Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

More than 500,000 Britons are believed to be using weight loss drugs but a waning appetite is not all they report – there’s also a lack of desire to drink alcohol ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Eli Lilly, a giant US pharma company, has launched its blockbuster drug for diabetes and obesity in India. The name of this ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...